Navigation Links
Bayer to Present New Data Evaluating Investigational Oncology Compounds at 2011 ECCO-ESMO Congress
Date:9/12/2011

ass="discStyle" type="disc">
  • Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)       
    • Abstract # 7141, Poster Session: Genitourinary Malignancies - Other
    • Sunday, September 25, 2011, 2:00-4:30pm CEST, Poster Area  

    • Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma
      • Abstract # 6576, Poster Session: Gastrointestinal Malignancies - Non-colorectal Cancer
      • Monday, September 26, 2011, 9:30am-12:00pm CEST, Poster Area

    About Radium-223 Chloride

    Radium-223 chloride is an investigational pharmaceutical containing an alpha-particle emitting nuclide in development for cancer patients with bone metastases. In September 2009, Bayer signed an agreement with Algeta ASA (Oslo, Norway) for the development and commercialization of radium-223 chloride. Under the terms of the agreement, Bayer will develop, apply for global health authority approvals, and commercialize radium-223 chloride globally, while Algeta retains an option for up to 50/50 co-promotion and profit-sharing in the United States.

    Radium-223 chloride is an investigational agent and is not approved by the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA) or other Health Authorities.  It was granted fast track designation by the FDA in August 2011.

    About Regorafenib

    Regorafenib is an investigational oral multi-kinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases (TK)(i) currently being investigated in clinical trials for its potential to treat patients with various tumor typ
    '/>"/>

    SOURCE Bayer HealthCare
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Nick Jonas and Bayer HealthCare Announce "Simple Inspirations" Contest to Motivate and Support Those Newly Diagnosed with Diabetes
    2. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
    3. Bayer HealthCare Provides Nearly $2.5 Million to Advance Hemophilia Research and Patient Care
    4. Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners
    5. Bayer Announces Farnam Companies Agreement to Halt Disputed Bio Spot® Ads
    6. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
    7. Bayers Discrimination Lawsuit Now Requires Extra-Strength Cure
    8. Bayer to Present Data on Investigational Oncology Compounds at 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)
    9. Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million
    10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
    11. Two New Studies in the British Medical Journal Find That Bayers Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
    (Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
    (Date:5/22/2015)...  In a sweeping analysis assessing the current state ... researchers conclude that there remains considerable room for ... age groups, but especially for adolescents and young adults. ... treatment, underscoring the need to address barriers to care ... type 1 patients achieve optimal metabolic control. ...
    Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
    ... SAN DIEGO, Feb. 17, 2011 Orexigen® Therapeutics, Inc. (Nasdaq: ... Graham Cooper, senior vice president, Finance, CFO and treasurer. Mr. ... has decided to leave the Company for personal reasons.  He ... accepting the CFO role in 2006.  Mr. Cooper will remain ...
    ... Feb. 17, 2011 In celebration of the 31st Annual ... NXTM ), a leading manufacturer of innovative dialysis products, today ... System One for home hemodialysis.  The System One is the ... the FDA. "This new milestone demonstrates growing ...
    Cached Medicine Technology:Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer 2Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer 3In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis 2In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis 3
    (Date:5/24/2015)... New York, New York (PRWEB) May 24, 2015 ... of testosterone treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has ... discuss the progress of the multidistrict litigation. According ... Court, Northern District of Illinois, the Conference will ... p.m. (In re: Testosterone Replacement Therapy Product Liability ...
    (Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Jay Krihak as its head of programmatic strategy ... its expertise and leadership position in the data ... sectors. , Krihak is an experienced, award-winning agency ... led sales planning teams for mobile platform Jumptap. ...
    (Date:5/23/2015)... 2015 On Saturday, May 23, 2015, over ... for Branches Florida City exactly five years to the day ... 2010. , A large fire tore through the Branches United ... 2010 in the middle of the night as neighbors, staff ... declared arson even though it is suspected that the fire ...
    (Date:5/23/2015)... San Diego, CA (PRWEB) May 23, 2015 ... businesses, especially small businesses, are finding it increasingly difficult ... Those businesses which fail to provide adequate insurance for ... healthcare for businesses been such an integral part of ... provide more affordable healthcare for businesses, Online USA Doctors ...
    (Date:5/23/2015)... 23, 2015 Manufacturers are now required to ... (HSPF) of 8.2. Experts in the field agree that the ... , The HSPF score is what miles per gallon is ... the unit. Although the minimum HSPF score has been raised ... an HSPF score north of 12. Indeed, the regulation was ...
    Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Medicx Media Solutions Expands Executive Team 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
    ... Oct. 11 SeaView IPA, an Oxnard, CA ... P. Bangasser Memorial,Award for Quality Improvement from the ... a special Awards Ceremony at the 6th,Annual Pay-for-Performance ... The IHA is a statewide leadership group ...
    ... 2007 Physicians at UT Southwestern Medical Center are the first ... radioactive pellet, or seed, is implanted into a mass or suspicious ... removal. , During the procedure, a radiologist uses a needle to ... of rice, into the mass. Once lodged, surgeons use a wand ...
    ... to Support Amendment to Hologic,s 1999 Equity ... ... Inc.,(Nasdaq: HOLX ), a leading provider of state-of-the-art diagnostic and,digital ... independent proxy advisory service, recommends that,Hologic stockholders vote "FOR" the Company,s ...
    ... Brochure Outlines Step-by-Step Process and Provides Sample Appeal,Letter, ... many seniors peace of mind that they will have,access ... individual,plan rules, the medicine that,s prescribed by the doctor ... but they need,to know what they can do about ...
    ... MEMPHIS, Tenn., Oct. 11 Baptist Memorial Health ... the University of Memphis,today, bringing its recent total ... million. Last month, Baptist contributed $1 million ... to Southwest Tennessee Community,College,s nursing, natural sciences and ...
    ... allows hospital pharmacies to accurately manage costs and ... ... 11 Omnicell, Inc.,(Nasdaq: OMCL ) a leading provider of ... efficiency, today,announced the Omnicell WorkflowRx 5.0 central pharmacy automation solution.,With its ...
    Cached Medicine News:Health News:MED3OOO Client Wins IHA Pay-for-Performance Award 2Health News:MED3OOO Client Wins IHA Pay-for-Performance Award 3Health News:New 'seed' therapy helps pinpoint breast tumors with more accuracy 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 4Health News:New Resource Explains What Seniors Can Do if Medicare Denies Coverage of Their Medicines 2Health News:Baptist Memorial Health Care Donates More Than $3 Million to Tennessee Universities and Colleges 2Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 2Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 3
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: